EKF Diagnostics (OTCMKTS:EKDHF) Shares Up 8.9% – Here’s Why

Shares of EKF Diagnostics Holdings plc (OTCMKTS:EKDHF) traded up 8.9% during mid-day trading on Monday . The company traded as high as $0.32 and last traded at $0.32. 20,000 shares were traded during mid-day trading, an increase of 0% from the average session volume of 20,000 shares. The stock had previously closed at $0.2939.

EKF Diagnostics Trading Up 8.9%

The firm’s fifty day moving average price is $0.32 and its 200-day moving average price is $0.35.

About EKF Diagnostics

EKF Diagnostics Holdings plc (OTCMKTS: EKDHF) is a global in vitro diagnostics company that develops, manufactures and markets a broad range of point-of-care and laboratory analyzers, reagents and consumables. The company’s product portfolio addresses key segments of the diagnostic testing market, including haematology, biochemistry, immunoassay, haemostasis and diabetes monitoring.

EKF Diagnostics offers peripheral blood analyzers designed for use in clinical laboratories, hospitals and veterinary clinics, along with handheld and benchtop devices for rapid on-site testing.